This likely indicates that Arrdc3 loss may generally enhance the survival/growth of Eμ-Myc lymphoma cells, which are highly apoptosis-prone, under normal (or slightly stressful; e.g. DMSO treatment/cell sorting) conditions (Figures S1A, B). The gene discussed is MYC; the disease is lymphoma.